FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20088911000001105: Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Apr 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68240101000001115 Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104307201000001113 Zolmitriptan 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Is a Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has active ingredient Zolmitriptan false Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has specific active ingredient Zolmitriptan true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) 6 tablet Has AMP True Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Inferred relationship Existential restriction modifier
Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) 12 tablet 2 x 6 tablets Has AMP True Zolmitriptan 5mg tablets (Glenmark Generics (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start